Simmunome is a biotechnology company focused on advancing immune profiling and biomarker discovery through innovative technology. The company specializes in developing tools and services that enhance the understanding of immune responses, aiding in the development of personalized medicine and therapeutic strategies. Simmunome's offerings are geared towards researchers and healthcare professionals seeking to improve patient outcomes through detailed immune system analysis.